The transcription factor RBP-J-mediated signaling is essential for dendritic cells to evoke efficient anti-tumor immune responses in mice

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Feng, Fan ^a,b   Wang, Yao Chun ^a   Hu, Xing Bin ^a   Liu, Xiao Wei ^a   Ji, Gang ^a   Chen, Yun Ru ^a   Wang, Lin ^a   He, Fei ^a   Dou, Guo Rui ^a   Liang, Liang ^a   Zhang, Hong Wei ^b   Han, Hua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOTCH RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RBP J; UNCLASSIFIED DRUG; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; RBPJ PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER INHIBITION; CELL SIZE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; SIGNAL TRANSDUCTION; SOLID TUMOR; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MELANOMA; FLOW CYTOMETRY; IMMUNOLOGY; LEWIS CARCINOMA; LYMPHOCYTE ACTIVATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR ASSOCIATED LEUKOCYTE;

MUS;

ANIMALS; ANTIGEN PRESENTATION; CARCINOMA, LEWIS LUNG; CELL SEPARATION; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, NOTCH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77951231780     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-90     Document Type: Article

References (39)

1. Moll H. Dendritic cells and host resistance to infection. Cell Microbiol 2003, 5:493-500. 10.1046/j.1462-5822.2003.00291.x, 12864809.
2. Melief CJ. Cancer immunotherapy by dendritic cells. Immunity 2008, 29:372-383. 10.1016/j.immuni.2008.08.004, 18799145.
3. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216. 10.1146/annurev.immunol.20.083001.084359, 11861602.
4. Ardavín C, Martínez del Hoyo G, Martín P, Anjuère F, Arias CF, Marín AR, Ruiz S, Parrillas V, Hernández H. Origin and differentiation of dendritic cells. Trends Immunol 2001, 22:691-700. 10.1016/S1471-4906(01)02059-2, 11739000.
5. Wan S, Zhou Z, Duan B, Morel L. Direct B cell stimulation by dendritic cells in a mouse model of lupus. Arthritis Rheum 2008, 58:1741-1750. 10.1002/art.23515, 18512810.
6. Kijima M, Yamaguchi T, Ishifune C, Maekawa Y, Koyanagi A, Yagita H, Chiba S, Kishihara K, Shimada M, Yasutomo K. Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci USA 2008, 105:7010-7015. 10.1073/pnas.0709919105, 2383942, 18458347.
7. LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat Immunol 2004, 5:899-908. 10.1038/ni1109, 15322541.
8. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005, 23:275-306. 10.1146/annurev.immunol.23.021704.115633, 15771572.
9. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426. 10.1038/nature06175, 17898760.
10. Dhodapkar MV, Dhodapkar KM, Palucka AK. Interactions of tumor cells with dendritic cells: Balancing immunity and tolerance. Cell Death Differ 2008, 15:39-50. 10.1038/sj.cdd.4402247, 2762352, 17948027.
11. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007, 117:1155-1166. 10.1172/JCI31422, 1857267, 17476345.
12. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008, 222:162-179. 10.1111/j.1600-065X.2008.00602.x, 18364001.
13. Gerner MY, Mescher MF. Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells. J Immunol 2009, 182:2726-2737. 10.4049/jimmunol.0803479, 2712950, 19234167.
14. Gabrilovich D. Mechanisms and functional significance of tumor induced dendritic-cell defects. Nat Rev Immunol 2004, 4:941-952. 10.1038/nri1498, 15573129.
15. Andrews DM, Maraskovsky E, Smyth MJ. Cancer vaccines for established cancer: how to make them better?. Immunol Rev 2008, 222:242-255. 10.1111/j.1600-065X.2008.00612.x, 18364006.
16. Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol 2003, 171:5940-5947.
17. Wei H, Wang H, Lu B, Li B, Hou S, Qian W, Fan K, Dai J, Zhao J, Guo Y. Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. Cancer Res 2008, 68:3854-3862. 10.1158/0008-5472.CAN-07-6051, 18483270.
18. So-Rosillo R, Small EJ. Sipuleucel-T (APC8015) for prostate cancer. Expert Rev, Anticancer Ther 2006, 6:1163-1167.
19. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006, 7:678-689. 10.1038/nrm2009, 16921404.
20. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signaling downstream of activated mammalian Notch. Nature 1995, 377:355-358. 10.1038/377355a0, 7566092.
21. Tamura K, Taniguchi Y, Minoguchi S, Sakai T, Tun T, Furukawa T, Honjo T. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H). Curr Biol 1995, 5:1416-1423. 10.1016/S0960-9822(95)00279-X, 8749394.
22. Kato H, Taniguchi Y, Kurooka H, Minoguchi S, Sakai T, Nomura-Okazaki S, Tamura K, Honjo T. Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. Development 1997, 124:4133-4141.
23. Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Regulation of dendritic cell differentiation by bone marrow stroma via different Notch ligands. Blood 2007, 109:507-515. 10.1182/blood-2006-05-025601, 1766374, 16973960.
24. Weijzen S, Velders MP, Elmishad AG, Bacon PE, Panella JR, Nickoloff BJ, Miele L, Kast WM. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J Immunol 2002, 169:4273-4278.
25. Ohishi K, Varnum-Finney B, Flowers D, Anasetti C, Myerson D, Bernstein ID. Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood 2000, 95:2847-2854.
26. Ohishi K, Varnum-Finney B, Serda RE, Anasetti C, Bernstein ID. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 2001, 98:1402-1407. 10.1182/blood.V98.5.1402, 11520788.
27. Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, Miele L, Gabrilovich DI. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 2001, 167:4458-4467.
28. Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood 2003, 102:3980-3988. 10.1182/blood-2003-04-1034, 12907456.
29. Caton ML, Smith-Raska MR, Reizis B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med 2007, 204:1653-1664. 2118632, 17591855.
30. Sekine C, Moriyama Y, Koyanagi A, Koyama N, Ogata H, Okumura K, Yagita H. Differential regulation of splenic CD8- dendritic cells and marginal zone B cells by Notch ligands. Int Immunol 2009, 21:295-301. 10.1093/intimm/dxn148, 19181931.
31. Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood 2006, 107:2694-2701. 10.1182/blood-2005-03-0970, 16357328.
32. Wang YC, Hu XB, He F, Feng F, Wang L, Li W, Zhang P, Li D, Jia ZS, Liang YM, Han H. Lipopolysaccharide-induced maturation of bone marrow-derived DCs is regulated by Notch signaling through the up-regulation of CXCR4. J Biol Chem 2009, 284:15993-16003. 10.1074/jbc.M901144200, 19357083.
33. Han H, Tanigaki K, Yamamoto N, Kuroda K, Yoshimoto M, Nakahata T, Ikuta K, Honjo T. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 2002, 14:637-645. 10.1093/intimm/dxf030, 12039915.
34. Bousso P. T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 2008, 8:675-684. 10.1038/nri2379, 19172690.
35. Long EO. Ready for prime time: NK cell priming by dendritic cells. Immunity 2007, 26:385-387. 10.1016/j.immuni.2007.04.001, 17459805.
36. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1995, 1:1297-1302. 10.1038/nm1295-1297, 7489412.
37. Hu XB, Feng F, Wang YC, Wang L, He F, Dou GR, Liang L, Zhang HW, Liang YM, Han H. Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia 2009, 11:32-38. 2606116, 19107229.
38. Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 2006, 312:1672-1676. 10.1126/science.1125703, 16778060.
39. Liu LN, Shivakumar R, Allen C, Fratantoni JC. Delivery of whole tumor lysate into dendritic cells for cancer vaccination. Methods Mol Biol 2008, 423:139-153. full_text, 18370195.